Literature DB >> 26742501

GOLGA2, encoding a master regulator of golgi apparatus, is mutated in a patient with a neuromuscular disorder.

Hanan E Shamseldin1, Alexis H Bennett2, Majid Alfadhel3, Vandana Gupta2, Fowzan S Alkuraya1,4.   

Abstract

Golgi apparatus (GA) is a membrane-bound organelle that serves a multitude of critical cellular functions including protein secretion and sorting, and cellular polarity. Many Mendelian diseases are caused by mutations in genes encoding various components of GA. GOLGA2 encodes GM130, a necessary component for the assembly of GA as a single complex, and its deficiency has been found to result in severe cellular phenotypes. We describe the first human patient with a homozygous apparently loss of function mutation in GOLGA2. The phenotype is a neuromuscular disorder characterized by developmental delay, seizures, progressive microcephaly, and muscular dystrophy. Knockdown of golga2 in zebrafish resulted in severe skeletal muscle disorganization and microcephaly recapitulating loss of function human phenotype. Our data suggest an important developmental role of GM130 in humans and zebrafish.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26742501      PMCID: PMC4975006          DOI: 10.1007/s00439-015-1632-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  The vesicle docking protein p115 binds GM130, a cis-Golgi matrix protein, in a mitotically regulated manner.

Authors:  N Nakamura; M Lowe; T P Levine; C Rabouille; G Warren
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

2.  Intrafamilial clinical heterogeneity of CSPP1-related ciliopathy.

Authors:  Tawfeg Ben-Omran; Reem Alsulaiman; Hussein Kamel; Ranad Shaheen; Fowzan S Alkuraya
Journal:  Am J Med Genet A       Date:  2015-05-22       Impact factor: 2.802

Review 3.  Human knockout research: new horizons and opportunities.

Authors:  Fowzan S Alkuraya
Journal:  Trends Genet       Date:  2014-12-09       Impact factor: 11.639

4.  Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210.

Authors:  Patrick Smits; Andrew D Bolton; Vincent Funari; Minh Hong; Eric D Boyden; Lei Lu; Danielle K Manning; Noelle D Dwyer; Jennifer L Moran; Mary Prysak; Barry Merriman; Stanley F Nelson; Luisa Bonafé; Andrea Superti-Furga; Shiro Ikegawa; Deborah Krakow; Daniel H Cohn; Tom Kirchhausen; Matthew L Warman; David R Beier
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

5.  RTTN Mutations Cause Primary Microcephaly and Primordial Dwarfism in Humans.

Authors:  Hanan Shamseldin; Anas M Alazami; Melanie Manning; Amal Hashem; Oana Caluseiu; Brahim Tabarki; Edward Esplin; Susan Schelley; A Micheil Innes; Jillian S Parboosingh; Ryan Lamont; Jacek Majewski; Francois P Bernier; Fowzan S Alkuraya
Journal:  Am J Hum Genet       Date:  2015-11-19       Impact factor: 11.025

6.  Cdc2 kinase directly phosphorylates the cis-Golgi matrix protein GM130 and is required for Golgi fragmentation in mitosis.

Authors:  M Lowe; C Rabouille; N Nakamura; R Watson; M Jackman; E Jämsä; D Rahman; D J Pappin; G Warren
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

7.  Accelerating matchmaking of novel dysmorphology syndromes through clinical and genomic characterization of a large cohort.

Authors:  Ranad Shaheen; Nisha Patel; Hanan Shamseldin; Fatema Alzahrani; Ruah Al-Yamany; Agaadir ALMoisheer; Nour Ewida; Shamsa Anazi; Maha Alnemer; Mohamed Elsheikh; Khaled Alfaleh; Muneera Alshammari; Amal Alhashem; Abdullah A Alangari; Mustafa A Salih; Martin Kircher; Riza M Daza; Niema Ibrahim; Salma M Wakil; Ahmed Alaqeel; Ikhlas Altowaijri; Jay Shendure; Amro Al-Habib; Eissa Faqieh; Fowzan S Alkuraya
Journal:  Genet Med       Date:  2015-12-03       Impact factor: 8.822

8.  The mitotic phosphorylation cycle of the cis-Golgi matrix protein GM130.

Authors:  M Lowe; N K Gonatas; G Warren
Journal:  J Cell Biol       Date:  2000-04-17       Impact factor: 10.539

9.  Genetics and genomic medicine in Saudi Arabia.

Authors:  Fowzan S Alkuraya
Journal:  Mol Genet Genomic Med       Date:  2014-07-30       Impact factor: 2.183

10.  Golgi disruption and early embryonic lethality in mice lacking USO1.

Authors:  Susie Kim; Adele Hill; Matthew L Warman; Patrick Smits
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more
  8 in total

1.  Structure of the Golgi apparatus is not influenced by a GAG deletion mutation in the dystonia-associated gene Tor1a.

Authors:  Sara B Mitchell; Sadahiro Iwabuchi; Hiroyuki Kawano; Tsun Ming Tom Yuen; Jin-Young Koh; K W David Ho; N Charles Harata
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

Review 2.  Discovery of mutations for Mendelian disorders.

Authors:  Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2016-04-11       Impact factor: 4.132

Review 3.  Golgi ribbon disassembly during mitosis, differentiation and disease progression.

Authors:  Jen-Hsuan Wei; Joachim Seemann
Journal:  Curr Opin Cell Biol       Date:  2017-04-05       Impact factor: 8.382

4.  Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice.

Authors:  Chunyi Liu; Mei Mei; Qiuling Li; Peristera Roboti; Qianqian Pang; Zhengzhou Ying; Fei Gao; Martin Lowe; Shilai Bao
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-27       Impact factor: 11.205

5.  Importin α phosphorylation promotes TPX2 activation by GM130 to control astral microtubules and spindle orientation.

Authors:  Haijing Guo; Jen-Hsuan Wei; Yijun Zhang; Joachim Seemann
Journal:  J Cell Sci       Date:  2021-02-19       Impact factor: 5.285

6.  TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.

Authors:  Austin A Larson; Peter R Baker; Miroslav P Milev; Craig A Press; Ronald J Sokol; Mary O Cox; Jacqueline K Lekostaj; Aaron A Stence; Aaron D Bossler; Jennifer M Mueller; Keshika Prematilake; Thierry Fotsing Tadjo; Charles A Williams; Michael Sacher; Steven A Moore
Journal:  Skelet Muscle       Date:  2018-05-31       Impact factor: 4.912

7.  EFHC1 variants in juvenile myoclonic epilepsy: reanalysis according to NHGRI and ACMG guidelines for assigning disease causality.

Authors:  Julia N Bailey; Christopher Patterson; Laurence de Nijs; Reyna M Durón; Viet-Huong Nguyen; Miyabi Tanaka; Marco T Medina; Aurelio Jara-Prado; Iris E Martínez-Juárez; Adriana Ochoa; Yolli Molina; Toshimitsu Suzuki; María E Alonso; Jenny E Wight; Yu-Chen Lin; Laura Guilhoto; Elza Marcia Targas Yacubian; Jesús Machado-Salas; Andrea Daga; Kazuhiro Yamakawa; Thierry M Grisar; Bernard Lakaye; Antonio V Delgado-Escueta
Journal:  Genet Med       Date:  2016-07-28       Impact factor: 8.822

Review 8.  Getting Sugar Coating Right! The Role of the Golgi Trafficking Machinery in Glycosylation.

Authors:  Zinia D'Souza; Farhana Taher Sumya; Amrita Khakurel; Vladimir Lupashin
Journal:  Cells       Date:  2021-11-23       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.